Federal Register / Vol. 66, No. 85 / Wednesday, May 2, 2001 / Notices 21991

commensurate with the level of research

activities defined by the CRADA

Research Plan. It is anticipated that PHS

facilities and/or those of the collaborator

will be utilized, as appropriate, for the

research activities as defined by the

Research Plan. NIHCC anticipates, in

addition, that the Collaborator, as

appropriate, will provide funding for

the project.

Party Contributions

The NIHCC anticipates that its role

may include, but not be limited to, the

following:

(1) Plan research studies, interpret

research results, and, as appropriate,

jointly publish the conclusions with the

collaborator;

(2) Provide collaborator with access to

existing NIHCC research data, both

already collected and yet to be collected

(except for medical or other personal

data regarding identifiable patients);

(3) Provide staff, expertise, and

materials for the development and

testing of promising application

products;

(4) Provide work space and

equipment for testing of any prototype

products developed.

The NIHCC anticipates that the role of

the successful collaborator will include

at least the following:

(1) Provide significant intellectual,

scientific, and technical expertise in the

development of relevant products;

(2) Plan research studies, interpret

research results, and, as appropriate,

jointly publish the conclusions; and

(3) Provide NIHCC a supply of

necessary materials, access to necessary

proprietary technology and/or data, and

as necessary for the project, staff and

funding in support of the research goals.

Other contributions may be necessary

for particular proposals.

Selection Criteria

Proposals submitted for consideration

should address, as best as possible and

to the extent relevant to the proposal,

each of the following:

(1) Expertise:

A. Expertise in the research and

development of diagnostic, prognostic,

and/or therapeutic products pertinent to

the technology; and

B. Ability to secure national

marketing and distribution of its

products (international distribution a

plus).

(2) Reliability as a research partner,

specifically:

A. Willingness to commit best effort

and to provide adequate and sustained

resources and/or funding, as

appropriate, to support the CRADA

studies;

B. Development of this technology, as

outlined in the CRADA Collaborator’s

proposal;

C. Ability to develop and produce

products in a timely manner, as

applicable (for example, as

demonstrated by a history of meeting

benchmarks in licenses);

D. Commitment to supporting the

advancement of scientific research, as

evidenced by a willingness to jointly

publish research results in a prompt

manner; and

E. Willingness to be bound by DHHS

and PHS policies regarding:

(i) the public distribution of research

tools,

(ii) the care and handling of animals,

and

(iii) protection of humans who are

subjects of research.

(3) Physical Resources:

A. An established headquarters, with

office space and basic office equipment;

B. Access to the organization during

business hours by telephone, facsimile,

courier, U.S. Post, e-mail, the WorldWide-Web, and, as appropriate, other

evolving information technologies; and

C. Sufficient financial and material

resources to support, at a minimum, the

anticipated activities of the CRADA to

meet the needs of NIHCC under the

proposal.

The collaborator is encouraged to

propose, in the written research

statement, related applications and

technologies other than those

specifically described herein.

Dated: April 23, 2001.

Kathleen Sybert,

Chief, TTB/NCI/NIH.

[FR Doc. 01–10934 Filed 5–1–01; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Eye Institute; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Advisory Eye Council.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Advisory

Eye Council.

Date: June 14–15, 2001.

Open: June 14, 2001, 8:30 a.m. to 5 p.m.

Agenda: Following opening remarks by the

Director, NEI, there will be presentations by

staff of the Institute and discussions

concerning Institute programs and policies.

Place: 6130 Executive Boulevard, Room G,

Rockville, MD 20852.

Closed: June 15, 2001, 8:30 a.m. to 1 p.m.

Closed: June 15, 2001, 8:30 a.m. to 1 p.m.

Agenda: To review and evaluate grant

applications.

Place: 6130 Executive Boulevard, Room G,

Rockville, MD 20852.

Contact Person: Lois DeNinno, National

Eye Institute, Executive Plaza South, Suite

350, 6120 Executive Blvd., MSC 7167,

Bethesda, MD 20892, 301–496–9110.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.867, Vision Research,

National Institutes of Health, HHS)

Dated: April 25, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10927 Filed 5–1–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute, Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, NHLBI.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

National Heart, Lung, and Blood

Institute, including consideration of

personnel qualifications and

performance, and the competence of

individual investigators, the disclosure

of which would constitute a clearly

unwarranted invasion of personal

privacy.

21992 Federal Register / Vol. 66, No. 85 / Wednesday, May 2, 2001 / Notices

Name of Committee: Board of Scientific

Counselors, NHLBI.

Date: June 7, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: National Institutes of Health, 9000

Rockville Pike, Building 10, Room 7S235,

Bethesda, MD 20892.

Contact Person: Elizabeth G. Nabel, MD,

Scientific Director for Clinical Research,

National Heart, Lung, and Blood Institute,

Division of Intramural Research, Building 10,

Room 8C103, MSC 1754, Bethesda, MD

20892, 301/496–1518.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: April 25, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10926 Filed 5–01–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development, Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Advisory Child Health and

Human Development Council.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552(b)(c)(4) and 552b(c)(6), Title 5

U.S.C., as amended. The grant

applications and the discussions could

disclose confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with

the grant applications, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Name of Committee: National Advisory

Child Health and Human Development

Council.

Date: June 4–5, 2001.

Open: June 4, 2001, 8:30 a.m. to 4 p.m.

Agenda: The agenda includes: Report of

the Director, NICHD; a presentation by the

Division of Epidemiology, Statistics and

Prevention Research Branch; and other

business of the Council.

Place: 9000 Rockville Pike, Building 31C,

Conference Room 6, Bethesda, MD 20892.

Closed: June 4, 2001, 4 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: 9000 Rockville Pike, Building 31C,

Conference Room 6, Bethesda, MD 20892.

Closed: June 5, 2001, 8:30 a.m. to be

adjournment.

Agenda: To review and evaluate grant

applications.

Place: 9000 Rockville Pike, Building 31C,

Conference Room 6, Bethesda, MD 20892.

Contact Person: Mary Plummer, Committee

Management Officer, Division of Scientific

Review, National Institute of Child Health

and Human Development, National Institutes

of Health, 6100 Executive Blvd., Room 5E03,

Bethesda, MD 20892, (301) 496–1485.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.209, Contraception and

Infertility Loan Repayment Program; 93.864,

Population Research; 93.865, Research for

Mothers and Children; 93.929, Center for

Medical Rehabilitation Research, National

Institutes of Health, HHS)

Dated: April 25, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10918 Filed 5–1–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

digestive and Kidney Diseases; Notice

of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the contact Person listed below in

advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasions of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Initial Review Group, Digestive Diseases and

Nutrition C Subcommittee.

Date: July 19–20, 2001.

Open: July 19, 2001, 1 p.m. to 1:30 p.m.

Agenda: To receive procedures and discuss

policies.

Place: Sheraton Crystal City, 1800 Jefferson

Davis Highway, Arlington, VA 22202.

Closed: July 19, 2001, 1:30 p.m. to

adjournment.

Agenda: To review and evaluate grant

applications.

Place: Sheraton Crystal City, 1800 Jefferson

Davis Highway, Arlington VA 22202.

Closed: July 20, 2001, 8 a.m. to

adjournment.

Agenda: To review and evaluate grant

applications.

Place: Sheraton Crystal City, 1800 Jefferson

Davis Highway, Arlington, VA 22202.

Contact Person: Carolyn Miles, PhD,

Scientific Research Administrator, Review

Branch, DEA, NIDDK, Room 755, 6707

Democracy Boulevard, National Institutes of

Health, Bethesda, MD 20892, (301) 594–7791.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: April 25, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10919 Filed 5–1–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,